Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases

<p>Abstract</p> <p>Background</p> <p>An advance in the treatment of schizophrenia is the development of long-acting intramuscular formulations of antipsychotics, such as olanzapine long-acting injection (LAI). During clinical trials, a post-injection syndrome characteri...

Full description

Bibliographic Details
Main Authors: Stefaniak Victoria J, Sorsaburu Sebastian, Zhao Fangyi, Brunner Elizabeth, McDonnell David P, Detke Holland C, Corya Sara A
Format: Article
Language:English
Published: BMC 2010-06-01
Series:BMC Psychiatry
Online Access:http://www.biomedcentral.com/1471-244X/10/43